New branding emphasises the company’s focus on the pharma sector.Read Announcement
CPhI Award nomination is for the company’s “Partnership for a Better World” project. Centroflora CMS has again been nominated for the CPhI Award in the category “Excellence in Pharma: Corporate Social Responsibility” for the project “Partnership for a Better World”. This is the second year in succession that the company has been in the running for the Award. Visit CPhI Award WebsiteRead Press Release
Please join us at our booth 11.0.B40 under the Brazilian Pavillion at CPhI Frankfurt on October 24 and 26, 2017.
Centroflora CMS is selected as a finalist for the CPhI Pharma Awards 2016 in the category Excellence in Pharma: Corporate Social ResponsibilityRead website
Please join us at our booth 3H10 under the Brazilian Pavillion at CPhI Barcelona on October 4 and 6, 2016.
We are pleased to announce that Centroflora CMS won the prestigious 2015 CPhI Pharma Awards for Excellence in Partnering & Outsourcing. Awarded by CPhI Worldwide (UBM EMEA), 16 finalists were invited to present their case during the first day of CPhI Worldwide in Madrid on October 13, 2015. After extensive deliberations, the judges announced the winners during a live ceremony across seven categories, one of which being “Excellence in Partnering & Outsourcing”.
Ahead of CPhI 2015, Centroflora CMS is announcing a major expansion of its product and services offering:
Please join us at our booth 8D20 under the Brazilian Pavillion at CPhI Madrid between October 13 and 15, 2015.
Centroflora Group receives the Brazilian Ministry of Environment 1st National Biodiversity Award in recognition of the Jaborandi Valorization Project.Read announcement
Boehringer Ingelheim awards Centroflora CMS the exclusive distribution rights for N-Butyl Scopolamine (SNBB) globally. This decision demonstrates and fully aligns with Boehringer Ingelheim long-term commitment to remain a key manufacturer of SNBB while Centroflora CMS is to assume market supply responsibilities as of January 1, 2015.
Please join us at our booth 5P73 under the Brazilian Pavillion at CPhI Paris between October 7 and 9, 2014.
Centroflora CMS has acquired the phytochemical API product portfolio from Boehringer Ingelheim with the intent to transfer and produce them in order to ensure an uninterrupted market supply. Centroflora CMS has also assumed the exclusive distribution of Centroflora’s Pilocarpine. Read CHE-Manager ArticleRead press release